About Us

Our name, 2seventy bioTM, is inspired by the maximum speed of translating human thought into action — 270 miles per hour. At 2seventy bio, we think in the language of time. It’s about timeTM we endeavor to outmaneuver cancer so the people we serve can have the chance for MORE…more time building stories with families and friends, experiencing their passions, and living their best lives in the big and small moments. Too many have lost time to cancer and we are wildly impatient to help change that.

It’s about time is also the restlessness we have to change the status quo and challenge ourselves to look at things from different perspectives. And we know that it’s about time we change our workplaces into human places that allow us to dream big, devise solutions, and deliver new therapies that are designed with the goal to "think" smarter and faster than cancer.

At 2seventy bio, we have the benefit of time and experience that we apply to our endeavors. We carry with us a legacy of deep care for patients and our people, thought leadership, learnings, and scientific expertise from our gene therapy and oncology roots. We build upon this strong foundation with our extensive knowledge in cell therapy, our expanding and robust research pipeline, and our vast experience across the continuum of drug development and commercialization.

And our time spent with collaborators is crucial. We work closely with patients, care partners, advocacy organizations, healthcare professionals, academic, and industry partners because we know we’re better together. It is this mindset and approach that will propel us forward because we know that time matters — every day, every minute, every second — to people living with cancer.

2seventy Leadership Team
click to learn more
Susan Abu-Absi, Ph.D.
Chief Technology & Manufacturing Officer
Chip Baird
Chief Financial Officer
Steven Bernstein, M.D.
Chief Medical Officer
Kevin Chin, M.D.
Head of Clinical Development
Philip Gregory, D.Phil.
Chief Scientific Officer
Nicola Heffron
Chief Operating Officer
Teresa Jurgensen, J.D.
General Counsel
Nick Leschly
Chief Kairos* Officer
Kathleen Munster
Senior Vice President, Enabling Functions (Quality, Facilities & IT)
Steven Shamah, Ph.D.
Head of Oncology Research
Jenn Snyder
Head of Corporate Affairs
Kathy Wilkinson
Head of People & Culture
*Kairos is an Ancient Greek word meaning the right, critical, or opportune moment
Board of Directors
Sarah Glickman
CFO, Criteo
Ramy Ibrahim, M.D.
CMO, bit.bio
Nick Leschly
Chief Kairos* Officer
Daniel S. Lynch
Chairman - Independent
Marcela Maus, M.D., Ph.D.
Mass General Cancer Center
Denice Torres, J.D.
Formerly Johnson & Johnson
Diversity, Equity, Inclusion and Belonging

At 2seventy bio, we believe that it’s about time that Diversity, Equity, Inclusion and Belonging become more than words. It is the core practice we are driven by in all we create. From our focus on patients, to how we are building our business and our culture, we believe diversity and belonging empower us to change the way we think, teach, and learn — from each other and about each other. Our mission is rooted in the belief that our cumulative and unique differences enable us to become better — better at our development of revolutionary scientific advancements and how we advance health equity by addressing cancer disparities with a goal of creating transformative treatments for those who need them. We strive to build an environment where we will deliver our best — that means having the hard conversations and doing the hard work — so we can all be unencumbered and inspired to celebrate who we are fully as human beings.

Compliance & Ethics

At 2seventy bio, we carry with us a legacy of deep care for patients, our people, and doing what is right by them. We ensure transparency in all areas of our business, conduct ourselves at all times as outlined in our Code of Business Conduct and Ethics, and hold ourselves accountable to meet expectations as a partner in this field – because we know we can’t do this alone.

Corporate Giving

We are committed to supporting the oncology community.

We believe in the work of the broader oncology community. 2seventy bio may provide funding to support programs and activities for healthcare professionals and the scientific community, patient and advocacy organizations, and our local communities.

Please contact grantsandsponsorships@2seventybio.com with questions or for more information on grants and sponsorships.

Medical

Continuing Medical Education Grants: 2seventy bio may provide Educational Grants to support the legitimate expenses for bona fide, independent educational or scientific programs and conferences.

Submit a Continuing Medical Education Grant Request

Documents Requested for Continuing Medical Education Grant Consideration:

  • Letter of Request (LOR) on educational organization’s letterhead (PDF), including:
    • Program/activity title
    • Date(s)
    • Location(s)
    • Description of proposed program/activity
    • Anticipated attendance
    • Funding amount requested from 2seventy bio
    • Whether or not requestor is seeking co-funding from other companies or entities
  • Estimated program/activity budget
  • Agenda (if an event)

Medical Sponsorships: 2seventy bio will consider the support of sponsorships that relate to disease states, therapeutic areas, or technology platforms of interest to 2seventy bio.

Submit a Medical Sponsorship Request

Documents Requested for Medical Sponsorship Consideration:

  • Letter of Request (LOR) on educational organization’s letterhead (PDF), including:
    • Program/activity title
    • Date(s)
    • Location(s)
    • Description of proposed program/activity
    • Anticipated attendance
    • Funding amount requested from 2seventy bio
    • Whether or not requestor is seeking co-funding from other companies or entities
  • Sponsorship levels and associated benefits (if applicable)

Patient Advocacy

Patient Advocacy: 2seventy bio is proud to collaborate with advocacy organizations and support their missions to improve the understanding of community needs and elevate awareness across the healthcare system. We will review restricted grants and sponsorship requests from nonprofit advocacy organizations described in Sections 501(c)(3) of the United States Internal Revenue Code and from similarly designated nonprofit/charitable organizations in countries outside of the United States. Requests should seek support of activities related to therapeutic areas or technology platforms of interest to 2seventy bio and be consistent with shared goals.

Please submit requests for support well in advance of the proposed program, event, or activity (60 days or more) to ensure adequate time for internal review, response, and payment of support.

Submit a Patient Advocacy Sponsorship Request

Submit a Patient Advocacy Education Grant Request

Documents Requested for Patient Advocacy Sponsorship or Education Grant Consideration

  • Letter of Request (LOR) on educational organization’s letterhead (PDF), including:
    • Program/activity title
    • Date(s)
    • Location(s)
    • Description of proposed program/activity
    • Anticipated impact of proposed program/activity
    • Funding amount requested from 2seventy bio
    • Whether or not requestor is seeking co-funding from other companies or entities
  • Estimated program/activity budget
  • Agenda (if an event)
  • Sponsorship levels and associated benefits (if applicable)
  • Copy of current 990 form (dated within the last 2 years)
  • 501(c)(3) designation letter
  • Current IRS W-9 form or equivalent foreign documentation (signed and dated within the last 12 months)

2seventy bio sets strict standards on all of our interactions with patient organization leaders, healthcare professionals, and other community partners.

2seventy bio reserves the right to modify, revise, or delete the terms and conditions of its corporate giving program at any time and without notice.